⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
Verizon Delivers Another Record-Breaking Quarter with 3Q 2026 Results Driven by Strong Postpaid Phone and Account Additions
globenewswire.com
VZ
Electra Refinery Construction Remains on Budget as Workforce Doubles
globenewswire.com
ELBM
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against XTI Aerospace, Inc. (XTIA), Innventure, Inc. (INV), and York Space Systems, Inc. (YSS) Announced by Holzer & Holzer, LLC
globenewswire.com
XTIA
YSS
INV
Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026
globenewswire.com
TNXP
Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting
globenewswire.com
ELDN
Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis
globenewswire.com
ORKA
Gildan Completes Sale of HanesBrands Australia
globenewswire.com
GIL
Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine
globenewswire.com
PLUR
Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026
globenewswire.com
FATE
Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026
globenewswire.com
CANF